Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-01 Sale |
2021-06-02 4:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $26.24 | $80,151 | 224,010 (Indirect Direct) |
View |
2021-05-03 Sale |
2021-05-04 4:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $30.56 | $93,361 | 227,065 (Indirect Direct) |
View |
2021-04-01 Sale |
2021-04-05 5:15 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $28.75 | $87,828 | 230,120 (Indirect Direct) |
View |
2021-03-01 Sale |
2021-03-02 5:56 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $30.48 | $93,112 | 233,175 (Indirect Direct) |
View |
2021-02-01 Sale |
2021-02-02 4:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $29.24 | $89,321 | 236,230 (Indirect Direct) |
View |
2021-01-08 Sale |
2021-01-11 7:54 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.12 | $281,200 | 274,581 (Indirect Direct) |
View |
2021-01-04 Sale |
2021-01-06 6:48 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,060 | $25.29 | $77,399 | 241,785 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-07 Exercise |
2021-01-11 7:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
7,500 | $0.615 | 274,581 (Direct) |
View |
2021-01-07 Exercise |
2021-01-11 7:54 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
7,500 | $0 | 274,581 (Direct) |
View |
2020-12-08 Option Award |
2020-12-09 8:53 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
77,580 | $0 | 322,425 (Direct) |
View |
2020-06-30 Option Award |
2020-12-09 8:53 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
1,245 | $17.07 | 322,425 (Direct) |
View |